Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort

Fig. 2

Incidence of the composite outcome by risk factor for HIV acquisition (panel a), HIV RNA (panel b), number of switches in the nucleoside/nucleotide backbone (panel c), and Fib-4 score (panel d). List of abbreviations MSM: men have sex with men, IDU: intravenous drug use, VL: HIV RNA viral load, Fib4: fibrosis 4 score

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us